2022
Comprehensive molecular profiling of pancreatic ductal adenocarcinoma in FNA, biopsy, and resection specimens
Razzano D, Bouza SJ, Hernandez PV, Wang M, Robert ME, Walther Z, Cai G. Comprehensive molecular profiling of pancreatic ductal adenocarcinoma in FNA, biopsy, and resection specimens. Cancer Cytopathology 2022, 130: 726-734. PMID: 35511415, DOI: 10.1002/cncy.22589.Peer-Reviewed Original ResearchConceptsFine-needle aspirationFine-needle biopsyPancreatic ductal adenocarcinomaOncomine Comprehensive AssayResection specimensMolecular alterationsMolecular testingFNB samplesDuctal adenocarcinomaTherapeutic implicationsSuccess rateComprehensive molecular analysisComprehensive molecular testingComprehensive molecular profilingPotential therapeutic implicationsSimilar success ratesResection casesKRAS mutationsFNB specimensFNA materialFNA specimensAmplification analysisMolecular profilingFusion assessmentGene mutations
2019
Molecular Testing on Pleural Fluid Samples
Oh S, Ronaghi R, Cai G. Molecular Testing on Pleural Fluid Samples. Seminars In Respiratory And Critical Care Medicine 2019, 40: 340-346. PMID: 31525809, DOI: 10.1055/s-0039-1695702.Peer-Reviewed Original ResearchConceptsPleural fluid analysisPleural effusionFluid analysisMalignant diseasePleural fluidMalignant pleural effusionPleural fluid samplesRoutine thoracentesisNonmalignant diseasesCommon manifestationAppropriate stagingCytologic evaluationSignificant prognosticTherapeutic implicationsMolecular testingEffusionTreatment implicationsDiseaseFluid samplesSignificant numberLow sensitivityThoracentesisEtiologyStagingCancer